Previous close | 14.42 |
Open | 14.40 |
Bid | 14.44 x 900 |
Ask | 14.45 x 1000 |
Day's range | 14.28 - 14.70 |
52-week range | 13.36 - 39.67 |
Volume | |
Avg. volume | 487,034 |
Market cap | 525.586M |
Beta (5Y monthly) | 0.90 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.56 |
Earnings date | 24 Apr 2024 - 29 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 18.87 |
Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.
Strength in Nevro's (NVRO) Senza Platform raises optimism about the stock.
Nevro's (NVRO) SI joint fusion device, Nevro1, gets FDA clearance for the use of a lateral screw NevroFix.